ADVANCED OPTICAL SENSING SOLUTIONS FOR A HEALTHIER AND SAFER WORLD.
Our goal for Halo is to create a new standard of care in POC and at-home testing by offering assay manufacturers a turnkey solution for the deployment and use of rapid tests.
MEET THE TEAM
Founded in 2013 as an MIT “Tough Tech” spinout, we’ve applied our expertise in optical sensing to develop the Halo Platform. Headquartered in Watertown, Massachusetts, the HALO team features 14 scientists, engineers, and business leaders designing and implementing innovative solutions for healthier people and a safer world.
Jason Cox, Ph.D.
Chief Executive Officer
Robert Deans, Ph.D.
Chief Technology Officer
Chief Strategy Officer
Joseph Walish, Ph.D.
Chief Product Owner
Mary Rose Durante
VP Business Operations
Sr. Director Marketing
Sr Software & Algo Eng.
Brian Fratto, Ph.D.
Product Owner/ R&D Eng.
Sean Hwang, Ph.D.
SCROLL TO SEE
Compliance testing should be repeatable with consistent outcomes and auditable results.
SCROLL TO SEE
WHAT MAKES HALO UNIQUE
Halo provides assay manufacturers with a turnkey LFA reader solution to enable at-home and POC lab-quality diagnostics.
Thoughtfully designed app reduces user error, enables consumer engagement and access to online marketplace for test purchase.
Highly reliable and providing consistent outcomes, Halo is a portable, low-powered device designed to offer lab-quality diagnostics wherever they are needed.
March 8, 2023
Watertown, Mass., March 8, 2023 – C2Sense, Inc., today announced the appointment of the Honorable Andrew Weber to its Board of Directors effective January 31, 2023.
February 1, 2023
Digital innovation and connected diagnostics can help address global health disparities, but it is essential to ensure health governance advances alongside new technologies.
January 4, 2023
C2Sense, Inc., a technology company developing a suite of diagnostic products for healthcare, wellness and safety, announced today the successful second closing of its $8M Series B financing round with participation from new and existing investors.
December 6, 2022
Halo launches a platform-dedicated website
November 2, 2022
Celebrating the first ever shipment of the Halo product!
October 23, 2022
Visit us at Booth #15036 at Pack Expo International - October 23 - 26 at McCormick Place, Chicago, IL USA.
August 25, 2022
C2Sense, Inc., is a technology company developing a suite of diagnostic products for healthcare, wellness and safety.
April 18, 2022
Halo™️ a Universal Fluorescence Reader Published in Frontiers in Public Health
C2Sense, Inc. has published a proof-of-concept study in Frontiers in Public Health demonstrating the sensitivity and specificity of its Halo™️ technology platform to detect SARS-CoV-2.
Halo is designed and developed by C2Sense. C2Sense is committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability. We aim to adhere as closely as possible to the Web Content Accessibility Guidelines (WCAG 2.0, Level AA), published by the World Wide Web Consortium (W3C). These guidelines explain how to make Web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly to everyone. Whilst C2Sense strives to adhere to the guidelines and standards for accessibility, it is not always possible to do so in all areas of the website and we are currently working to achieve this. Be aware that due to the dynamic nature of the website, minor issues may occasionally occur as it is updated regularly. We are continually seeking out solutions that will bring all areas of the site up to the same level of overall web accessibility.
If you have any comments and or suggestions relating to improving the accessibility of our site, please don't hesitate to contact us. Your feedback will help us make improvements.
480 Arsenal Way, Suite #110
Watertown, MA 02472